Ipratropium
Back to searchMolecule Structure
Scientific Name
Ipratropium
Description of the Drug
Ipratropium is an anticholinergic drug used in the control of symptoms related to bronchospasm in chronic obstructive pulmonary disease (COPD).
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00332
http://www.drugbank.ca/drugs/DB00332
Brand Name(s)
Not Available
Company Owner(s)
Cipla Ltd, Watson Laboratories Inc, Actavis Mid Atlantic Llc, Luoxin Aurovitas Pharma Chengdu Co Ltd, Amneal Pharmaceuticals Llc, Fosun Pharma Usa Inc, Boehringer Ingelheim Pharmaceuticals Inc, The Ritedose Corp, Landela Pharmaceutical, Watson Laboratories Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Muscarinic acetylcholine receptor M3 | SINGLE PROTEIN | ANTAGONIST | CHEMBL245 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL7862886 | |||
| DrugBank | DB00332 | |||
| EPA CompTox Dashboard | DTXSID9048437 | |||
| DrugCentral | 1475 | |||
| rxnorm | IPRATROPIUM BROMIDE | IPRATROPIUM BROMIDE MONOHYDRATE | ATROVENT | IPRATROPIUM |
| KEGG Ligand | C07052 |
